| Primary |
| Cataract Operation |
23.3% |
| Intraocular Pressure Increased |
21.7% |
| Epilepsy |
6.7% |
| Angle Closure Glaucoma |
5.0% |
| Glaucoma |
5.0% |
| Intraocular Pressure Test |
5.0% |
| Miosis |
5.0% |
| Dry Eye |
3.3% |
| Dry Mouth |
3.3% |
| Eye Disorder |
3.3% |
| Pupillary Disorder |
3.3% |
| Surgery |
3.3% |
| Eye Laser Surgery |
1.7% |
| Iridotomy |
1.7% |
| Lactose Intolerance |
1.7% |
| Macular Degeneration |
1.7% |
| Mydriasis |
1.7% |
| Post Procedural Complication |
1.7% |
| Sialoadenitis |
1.7% |
|
| Visual Acuity Reduced |
16.1% |
| Drug Ineffective |
9.7% |
| Vitritis |
9.7% |
| Corneal Oedema |
6.5% |
| Intraocular Pressure Increased |
6.5% |
| Vitreous Detachment |
6.5% |
| Anaphylactic Reaction |
3.2% |
| Angle Closure Glaucoma |
3.2% |
| Blindness Transient |
3.2% |
| Chronic Hepatitis |
3.2% |
| Drug Toxicity |
3.2% |
| Hangover |
3.2% |
| Lacrimation Increased |
3.2% |
| Lens Dislocation |
3.2% |
| Rash |
3.2% |
| Restless Legs Syndrome |
3.2% |
| Swelling |
3.2% |
| Unevaluable Event |
3.2% |
| Vision Blurred |
3.2% |
| Vitreous Disorder |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
37.3% |
| Drug Abuse |
31.4% |
| Intraocular Pressure Increased |
10.7% |
| Cataract Operation |
5.1% |
| Angle Closure Glaucoma |
4.3% |
| Glaucoma |
4.3% |
| Anterior Chamber Disorder |
2.5% |
| Drug Use For Unknown Indication |
1.0% |
| Open Angle Glaucoma |
0.6% |
| Asthma |
0.4% |
| Cycloplegia |
0.4% |
| Eye Inflammation |
0.4% |
| Local Anaesthesia |
0.4% |
| Cataract |
0.3% |
| Hypertension |
0.3% |
| Surgery |
0.3% |
| Blood Sodium |
0.1% |
| Dementia |
0.1% |
| Intraocular Pressure Test |
0.1% |
| Psoriasis |
0.1% |
|
| Visual Acuity Reduced |
18.5% |
| Drug Ineffective |
10.8% |
| Intraocular Pressure Increased |
10.8% |
| Vitritis |
9.2% |
| Inflammation |
7.7% |
| Vision Blurred |
7.7% |
| Retinopathy |
6.2% |
| Rectal Haemorrhage |
4.6% |
| Bradycardia |
3.1% |
| Conjunctivitis Allergic |
3.1% |
| Surgery |
3.1% |
| Visual Acuity Tests Abnormal |
3.1% |
| Anaphylactic Reaction |
1.5% |
| Anterior Chamber Disorder |
1.5% |
| Condition Aggravated |
1.5% |
| Flat Anterior Chamber Of Eye |
1.5% |
| Hyphaema |
1.5% |
| Intraocular Pressure Fluctuation |
1.5% |
| Iridocyclitis |
1.5% |
| Nausea |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.4% |
| Drug Use For Unknown Indication |
10.6% |
| Glaucoma |
7.1% |
| Pain |
5.8% |
| Rheumatoid Arthritis |
5.6% |
| Asthma |
4.5% |
| Hypertension |
2.9% |
| Back Pain |
2.8% |
| Diabetes Mellitus |
2.6% |
| Osteoporosis |
2.4% |
| Anxiety |
2.1% |
| Depression |
2.1% |
| Cardiac Disorder |
2.0% |
| Dry Mouth |
1.9% |
| Prophylaxis |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Multiple Myeloma |
1.7% |
| Complex Regional Pain Syndrome |
1.6% |
| Sjogren's Syndrome |
1.2% |
| Eye Disorder |
1.2% |
|
| Vomiting |
14.5% |
| Weight Increased |
8.0% |
| Death |
7.2% |
| Visual Acuity Reduced |
7.2% |
| Weight Decreased |
7.2% |
| Drug Ineffective |
5.8% |
| Vision Blurred |
5.1% |
| Intraocular Pressure Increased |
4.3% |
| Nausea |
4.3% |
| Respiratory Failure |
4.3% |
| Transient Ischaemic Attack |
4.3% |
| Bronchitis |
3.6% |
| Oedema Peripheral |
3.6% |
| Diarrhoea |
2.9% |
| Flushing |
2.9% |
| Glomerular Filtration Rate Decreased |
2.9% |
| Headache |
2.9% |
| Hypotension |
2.9% |
| Pain |
2.9% |
| Pelvic Fracture |
2.9% |
|
